Shared mechanisms for opioid tolerance and a transition to chronic pain

Journal of Neuroscience

Volumn 30, Issue 13, 2010, Pages 4660-4666

  Joseph, Elizabeth K ^a   Reichling, David B ^a   Levine, Jon D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; EMULSIFYING AGENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; INFLAMMOGEN; MU OPIATE RECEPTOR ANTAGONIST; OPIATE; PROSTAGLANDIN E2; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME INHIBITION; HYPERALGESIA; INFLAMMATION; MALE; NOCICEPTIVE RECEPTOR; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; SENSORY NERVE; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ANALGESICS, OPIOID; ANIMALS; CARRAGEENAN; CHRONIC DISEASE; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HYPERALGESIA; INFLAMMATION; MALE; NOCICEPTORS; OPIOID-RELATED DISORDERS; PAIN; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77950657123     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5530-09.2010     Document Type: Article

References (62)

1. Aicher SA, Punnoose A, Goldberg A (2000) μ-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn. J Neurosci 20:4345-4354. (Pubitemid 30365705)
2. Aley KO, Levine JD (1997) Multiple receptors involved in peripheral alpha 2, mu, and Al antinociception, tolerance, and withdrawal. J Neurosci 17:735-744.
3. Aley KO, Green PG, Levine JD (1995) Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci 15:8031-8038. (Pubitemid 26006909)
4. Aley KO, Messing RO, Mochly-Rosen D, Levine JD (2000) Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 20:4680-4685. (Pubitemid 30396633)
5. Bailey CP, Kelly E, Henderson G (2004) Protein kinase C activation enhances morphine-induced rapid desensitization of mu-opioid receptors in mature rat locus ceruleus neurons. Mol Pharmacol 66:1592-1598. (Pubitemid 39564786)
6. Bianchi E, Lehmann D, Vivoli E, Norcini M, Ghelardini C (2009) Involvement of PLC-{beta}3 in the effect of morphine on memory retrieval in passive avoidance task. J Psychopharmacol. Advance online publication. Retrieved May 15, 2009. doi:10.1177/0269881108102013.
7. Bigal ME, Lipton RB (2009) Overuse of acute migraine medications and migraine chronifcation. Curr Pain Headache Rep 13:301-307.
8. Biondi DM (2003) Opioid resistance in chronic daily headache: a synthesis of ideas from the bench and bedside. Curr Pain Headache Rep 7:67-75.
9. Brillet K, Kieffer BL, Massotte D (2003) Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening. BMC Pharmacol 3:14. (Pubitemid 38729264)
10. Chakrabarti S, Regec A, Gintzler AR (2005) Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure. Brain Res Mol Brain Res 135:217-224. (Pubitemid 40602413)
11. Chen L, Malarick C, Seefeld L,Wang S, Houghton M, Mao J (2009) Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 143:65-70.
12. Chu LF, Angst MS, Clark D (2008) Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 24:479-496.
13. Compton MA (1994) Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Symptom Manage 9:462-473.
14. da Silva Torres IL, Cucco SN, Bassani M, Duarte MS, Silveira PP, Vasconcellos AP, Tabajara AS, Dantas G, Fontella FU, Dalmaz C, Ferreira MB (2003) Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration. Neurosci Res 45:277-283. (Pubitemid 36298810)
15. Dina OA, Messing RO, Levine JD (2006) Ethanol withdrawal induces hyperalgesia mediated by PKCepsilon. Eur J Neurosci 24:197-204.
16. Dina OA, Khasar SG, Gear RW, Levine JD (2009) Activation of Gi induces mechanical hyperalgesia poststress or inflammation. Neuroscience 160:501-507.
17. Fazli-Tabaei S, Yahyavi SH, Alagheband P, Sarnie HR, Safari S, Rastegar F, Zarrindast MR (2005) Cross-tolerance between antinociception induced by swim-stress and morphine in formalin test. Behav Pharmacol 16:613-619. (Pubitemid 41682195)
18. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM (2008) Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine (Phila Pa 1976) 33:199-204.
19. Galeotti N, Stefano GB, Guarna M, Bianchi E, Ghelardini C (2006) Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain 123:294-305.
20. Girardot MN, Holloway FA ( 1984) Intermittent cold water stress-analgesia in rats: cross-tolerance to morphine. Pharmacol Biochem Behav 20: 631-633.
21. Han SK, Mancino V, Simon MI (2006) Phospholipase Cbeta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons. Neuron 52:691-703. (Pubitemid 44781169)
22. Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B (2009) Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain 10:316-322.
23. Hucho TB, Dina OA, Levine JD (2005) Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 25:6119-6126.
24. Joseph EK, Levine JD (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 20:2896-2902. (Pubitemid 40007283)
25. Joseph EK, Chen X, Khasar SG, Levine JD (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107:147-158. (Pubitemid 38058710)
26. Joseph EK, Bogen O, Alessandri-Haber N, Levine JD (2007) PLC-beta 3 signals upstream of PKC epsilon in acute and chronic inflammatory hyperalgesia. Pain 132:67-73. (Pubitemid 47494562)
27. Joseph EK, Chen X, Bogen O, Levine JD (2008) Oxaliplatin acts on IB4positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9:463-472.
28. Kalso E, Edwards JE, Moore RA, McQuay HJ (2004) Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112: 372-380. (Pubitemid 39550738)
29. Kelly E, Bailey CP, Henderson G (2008) Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 153 [Suppl 1]:S379-S388.
30. Khasar SG, Ho T, Green PG, Levine JD (1994) Comparison of prostaglandin El- and prostaglandin E2-induced hyperalgesia in the rat. Neuroscience 62:345-350. (Pubitemid 2141899)
31. Khasar SG, Burkham J, Dina OA, Brown AS, Bogen O, Alessandri-Haber N, Green PG, Reichling DB, Levine JD (2008) Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain. J Neurosci 28:5721-5730.
32. King AP, Hall KE, Macdonald RL (1999) kappa-and mu-Opioid inhibition of N-type calcium currents is attenuated by 4beta-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 289:312-320.
33. Kline RH 4th, Wiley RG (2008) Spinal mu-opioid receptor-expressing dorsal horn neurons: role in nociception and morphine antinociception. J Neurosci 28:904-913.
34. Kohno T, Ji RR, Ito N, Allchrone AJ, Befort K, Karchewski LA, Woolf CJ (2005) Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 117:77-87. (Pubitemid 41764774)
35. Lewis JW, Sherman JE, Liebeskind JC (1981) Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine. J Neurosci 1:358-363.
36. Liu JG, Anand KJ (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38:1-19.
37. Liu JG, Prather PL (2001) Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Mol Pharmacol 60:53-62.
38. Mao J, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259-274.
39. Mathew NT, Stubits E, Nigam MP (1982) Transformation of episodic migraine into daily headache: analysis of factors. Headache 22:66-68. (Pubitemid 12190412)
40. Mathews JL, Smrcka AV, Bidlack JM (2008) A novel Gbetagamma-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence. J Neurosci 28:12183-12189.
41. McCleane G, Smith HS (2007) Opioids for persistent noncancer pain. Anesthesiol Clin 25:787-807.
42. Mercadante S, Arcuri E (2005) Hyperalgesia and opioid switching. Am. J Hosp Palliat Care 22:291-294.
43. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H, Yu L (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 15:2396-2406.
44. Murthy KS, Makhlouf GM (1996) Opioid mu, delta, and kappa receptorinduced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Mol Pharmacol 50:870-877.
45. Newton PM, Kim JA, McGeehan AJ, Paredes JP, Chu K, Wallace MJ, Roberts AJ, Hodge CW, Messing RO (2007) Increased response to morphine in mice lacking protein kinase C epsilon. Genes Brain Behav 6:329-338. (Pubitemid 46800532)
46. Ono T, Inoue M, Rashid MH, Sumikawa K, Ueda H (2002) Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism. Neurochem lnt 41:399-407. (Pubitemid 35232325)
47. Parada CA, Yeh JJ, Joseph EK, Levine JD (2003) Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 17:1847-1852.
48. Parada CA, Reichling DB, Levine JD (2005) Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. Pain 113:185-190.
49. Reichling DB, Levine JD (2009) Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 32:611-618.
50. Rosenblum A, Marsch LA, Joseph H, Portenoy RK (2008) Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 16:405-416.
51. Sánchez-Blázquez P, Gómez-Serranillos P, Garzón J (2001) Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia. Brain Res Bull 54:229-235.
52. Savage SR (1996) Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 11:274-286. (Pubitemid 26129963)
53. Shi TJ, Liu SX, Hammarberg H, Watanabe M, Xu ZQ, Hökfelt T (2008) Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain. Proc Natl Acad Sci U S A 105:20004-20008.
54. Smith FL, Lohmann AB, Dewey WL (1999) Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br J Pharmacol 128:220-226. (Pubitemid 29425288)
55. Szikszay M, Benedek G (1989) Tolerance to morphine induced by chronic mild environmental stressors. Acta Physiol Hung 73:447-453. (Pubitemid 20068817)
56. Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadéc W (2004) Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence. J Pharmacol Exp Ther 308:512-520. (Pubitemid 38134212)
57. Wang HY, Burns LH (2006) Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein. J Neurobiol 66:1302-1310.
58. Watkins LR, Hutchinson MR, Rice KC, Maier SF (2009) The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 30:581-591.
59. Webster BS, Verma SK, Gatchel RJ (2007) Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine (Phila Pa 1976) 32:2127-2132.
60. Wiesenfeld-Hallin Z, Xu XJ, Hökfelt T (2002) The role of spinal cholecystokinin in chronic pain states. Pharmacol Toxicol 91:398-403. (Pubitemid 36138721)
61. Wilkinson SM, Becker WJ, Heine JA (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41:303-309.
62. Xie W, Samoriski GM, McLaughlin JP, Romoser VA, Smrcka A, Hinkle PM, Bidlack JM, Gross RA, Jiang H, Wu D (1999) Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids. Proc Natl Acad Sci U S A 96:10385-10390. (Pubitemid 29422567)